Top compounds associated with response to CTSD


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K16147474 CTRPv2 pan-cancer AAC 0.039 0.4
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.033 0.4
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.4
mRNA KU-60019 CTRPv2 pan-cancer AAC -0.034 0.4
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.034 0.4
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.045 0.4
mRNA istradefylline CTRPv2 pan-cancer AAC -0.054 0.4
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA Bortezomib gCSI pan-cancer AAC -0.061 0.4
mRNA BRD-K42260513 CTRPv2 pan-cancer AAC -0.053 0.4
Download CSV